Article
Transcatheter Arterialization Provides Safe and Effective Treatment for No-option CLI
December 1, 2023
Clinical question: Is transcatheter arterialization of lower extremity deep veins safe and effective in preventing above-ankle amputation in patients with advanced chronic limb ischemia (CLI) who are...
Article
Weighing Benefits and Risks of Indefinite Anticoagulation in First Unprovoked VTE
October 2, 2023
Clinical question: Is indefinite anticoagulation beneficial for patients with a first unprovoked venous thromboembolism (VTE) after initial treatment? Dr. Sheikh Background: VTE is a chronic,...
Article
Surgery May Be Better Than Endovascular Intervention for Some CLTI Patients
June 1, 2023
Dr. Fadden Clinical question: Which is a better approach for patients with chronic limb-threatening ischemia (CLTI): surgery or endovascular therapy? Background: CLTI is a complication of...
Article
Recurrence of VTE Associated with COVID-19 is Unlikely After Stopping Anticoagulation
June 1, 2023
Dr. Sullivan Clinical question: How long should anticoagulation be continued after COVID-19-associated venous thromboembolism (VTE)? Background: COVID-19 infection is associated with an...
Article
FAST Program Implementation Guide Success
February 1, 2023
Jefferson Antithrombotic Therapy Team. Front row L to R: Photi Galanis, MD, Julia Westfield, Heather Yenser, CRNP. Back row L to R: Lynda Thomson, PharmD, Dina Orapallo, CRNP, Geno Merli, MD, Tony...
Article
Consider post-discharge VTE prophylaxis for COVID-19 patients
April 1, 2022
Dr. Indovina Clinical question: Should extended post-discharge venous thromboembolism (VTE) prophylaxis be prescribed for patients with COVID-19? Background: While VTE prophylaxis during...
Article
Higher-than-expected recurrent VTE found in patients with isolated SSPE
April 1, 2022
Dr. Munoa Clinical question: What is the recurrence rate of venous thromboembolism (VTE) in patients with isolated subsegmental pulmonary embolisms (SSPE) managed without...
Article
Direct oral anticoagulants may be safe in cancer-related venous thromboembolisms, but use caution with gastrointestinal malignancies
February 3, 2022
Clinical question: Are direct oral anticoagulants (DOACs) a suitable alternative to low molecular weight heparin (LMWH) for treatment of venous thromboembolism (VTE) in patients with underlying...
News
D-dimer thresholds rule out PE in meta-analysis
December 14, 2021
Data from a large review support use of D-dimer levels to diagnose PE without imaging.
News
Apixaban outmatches rivaroxaban for VTE in study
December 6, 2021
These real-world findings may guide selection of initial anticoagulant therapy, according to authors of the paper.